GSRRX | VSTSX | GSRRX / VSTSX | |
Total Expense Ratio | 1.26 | 0.01 | 12,600% |
Annual Report Gross Expense Ratio | 1.52 | 0.01 | 15,200% |
Fund Existence | 13 years | 9 years | - |
Gain YTD | 5.225 | 8.300 | 63% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 442M | 1.91T | 0% |
Annual Yield % from dividends | 1.22 | 1.23 | 100% |
Returns for 1 year | -4.44 | 17.78 | -25% |
Returns for 3 years | 6.24 | 60.72 | 10% |
Returns for 5 years | 30.15 | 93.67 | 32% |
Returns for 10 years | -36.06 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IHI | 61.43 | 0.75 | +1.24% |
iShares US Medical Devices ETF | |||
GSC | 50.97 | 0.41 | +0.81% |
Goldman Sachs Small Cap Equity ETF | |||
QLTI | 25.79 | 0.04 | +0.14% |
GMO International Quality ETF | |||
DBND | 45.85 | 0.06 | +0.13% |
DoubleLine Opportunistic Core Bond ETF | |||
KEMQ | 22.94 | -0.37 | -1.58% |
KraneShares Em Mkts Cnsmr Tech ETF |